(Q37928585)

25 August 2017

1 reference

title

The interplay of cholinergic function, attention, and falls in Parkinson's disease (English)

1 reference

25 August 2017

1 reference

1 reference

2

Lynn Rochester

1 reference

25 August 2017

Alison Yarnall

1

0 references

David Burn

object named as

David J Burn

series ordinal

3

0 references

language of work or name

English

0 references

publication date

6 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

26

1 reference

25 August 2017

issue

14

1 reference

25 August 2017

page(s)

2496-2503

1 reference

Stages in the development of Parkinson's disease-related pathology

25 August 2017

cites work

1 reference

Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity

21 January 2018

1 reference

Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model

21 January 2018

1 reference

Medication impairs probabilistic classification learning in Parkinson's disease.

21 January 2018

1 reference

'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa

21 January 2018

1 reference

High-speed memory scanning in Parkinson's disease: adverse effects of levodopa

21 January 2018

1 reference

Effects of levodopa on motor sequence learning in Parkinson's disease

21 January 2018

1 reference

Acetylcholine-dopamine balance hypothesis in the striatum: an update

21 January 2018

1 reference

Cholinergic interneuron characteristics and nicotinic properties in the striatum

21 January 2018

1 reference

Acetylcholine in mind: a neurotransmitter correlate of consciousness?

21 January 2018

1 reference

The pedunculopontine nucleus and Parkinson's disease

21 January 2018

1 reference

Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus

21 January 2018

1 reference

A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance.

21 January 2018

1 reference

Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease

21 January 2018

1 reference

Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease

21 January 2018

1 reference

The locus ceruleus and dementia in Parkinson's disease

21 January 2018

1 reference

The morphological basis of mental dysfunction in Parkinson's disease

21 January 2018

1 reference

The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease

21 January 2018

1 reference

The pedunculopontine nucleus in Parkinson's disease.

21 January 2018

1 reference

Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients.

21 January 2018

1 reference

Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family?

21 January 2018

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

Benefits of rivastigmine on attention in dementia associated with Parkinson disease

21 January 2018

1 reference

Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.

21 January 2018

1 reference

Individual variation in a cholinergic receptor gene modulates attention.

21 January 2018

1 reference

Genetic variation of CHRNA4 does not modulate attention in Parkinson's disease

21 January 2018

1 reference

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

21 January 2018

1 reference

Risk of dementia in Parkinson's disease: a community-based, prospective study.

21 January 2018

1 reference

Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease

21 January 2018

1 reference

Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease

21 January 2018

1 reference

Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers

21 January 2018

1 reference

Memory and executive function impairment predict dementia in Parkinson's disease.

21 January 2018

1 reference

Dementia associated with Parkinson's disease

21 January 2018

1 reference

Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.

21 January 2018

1 reference

Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia

21 January 2018

1 reference

History of falls in Parkinson disease is associated with reduced cholinergic activity

21 January 2018

1 reference

Cholinergic dysfunction in diseases with Lewy bodies.

21 January 2018

1 reference

Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies

21 January 2018

1 reference

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study

21 January 2018

1 reference

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.

21 January 2018

1 reference

The cholinergic system and Parkinson disease

21 January 2018

1 reference

Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype.

21 January 2018

1 reference

Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia.

21 January 2018

1 reference

Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study

21 January 2018

1 reference

Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study

21 January 2018

1 reference

Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs

21 January 2018

1 reference

Cholinergic-dependent cognitive deficits in Parkinson's disease.

21 January 2018

1 reference

Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients

21 January 2018

1 reference

Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome

21 January 2018

1 reference

Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance.

21 January 2018

1 reference

Serum anticholinergic activity and motor performance in elderly persons

21 January 2018

1 reference

Uncertainty, neuromodulation, and attention

21 January 2018

1 reference

Prospective study of hallucinations and delusions in Parkinson's disease

21 January 2018

1 reference

Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study

21 January 2018

1 reference

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors

21 January 2018

1 reference

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

21 January 2018

1 reference

Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.

21 January 2018

1 reference

Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness

21 January 2018

1 reference

Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations.

21 January 2018

1 reference

Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease

21 January 2018

1 reference

Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex.

21 January 2018

1 reference

Short latency inhibition of human hand motor cortex by somatosensory input from the hand

21 January 2018

1 reference

Neurophysiological predictors of long term response to AChE inhibitors in AD patients

21 January 2018

1 reference

Functional evaluation of cerebral cortex in dementia with Lewy bodies

21 January 2018

1 reference

A meta-analysis of six prospective studies of falling in Parkinson's disease

21 January 2018

1 reference

Fear of falling is independently associated with recurrent falls in patients with Parkinson's disease: a 1-year prospective study.

21 January 2018

1 reference

Bone and mineral metabolism in older adults with Parkinson's disease

21 January 2018

1 reference

The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years

21 January 2018

1 reference

Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes

21 January 2018

1 reference

Tests of dorsolateral frontal function correlate with objective tests of postural stability in early to moderate stage Parkinson's disease

21 January 2018

1 reference

Attention and the control of posture and gait: a review of an emerging area of research

21 January 2018

1 reference

The multiple tasks test. Strategies in Parkinson's disease

21 January 2018

1 reference

Dual tasking, gait rhythmicity, and Parkinson's disease: which aspects of gait are attention demanding?

21 January 2018

1 reference

Gait changes in older adults: predictors of falls or indicators of fear.

21 January 2018

1 reference

Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa.

21 January 2018

1 reference

Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease

21 January 2018

1 reference

A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations

21 January 2018

1 reference

Cognitive impairment patterns in Parkinson's disease with visual hallucinations.

21 January 2018

1 reference

Executive functions are impaired in patients with Parkinson's disease with visual hallucinations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.23932

1 reference

25 August 2017

1 reference